Temozolomide in Treating Patients With Relapsed or Progressive Small Cell Lung Cancer
Clinical trial NCT00022711 · COMPLETED
Trial details
- NCT number
- NCT00022711
- Sponsor
- Fox Chase Cancer Center
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2002-01-01
- Primary completion
- 2004-01-01
- Enrollment
- 7
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.